Drugs / d-limonene
d-limonene
also known as
limonene · Cajeputene · Cinene · Dipenten · Dipentene · Dipentene no. 122 · Eulimen · FEMA NO. 2633 · +8 more
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06378957 | Feb 2025 → Jul 2027 expected | — | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 1 | NCT04392622 | Feb 2021 → Aug 2027 expected | — | Stanford University | Recruiting | No outcome recorded |
| Phase 1 | NCT03609853 | Apr 2019 → Jun 2022 | — | Johns Hopkins University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04091789 | Sep 2019 → Mar 2020 | dysmenorrhea, migraine disorder, mood disorder | Pure Green | Unknown | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 0 | NCT04853082 Comparator | Feb → Oct 2021 | fatty liver disease | Hongsheng Tan | Completed | No outcome recorded |
| Phase 2 | NCT05525260 Comparator | Feb 2023 → Feb 2024 | pulmonary coin lesion | Shanghai Jiao Tong University School of Medicine | Unknown | No outcome recorded |
Evidence & citations 20 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | d-limonene | “This study explores the safety of d-limonene, a commercially-available dietary supplement (food) as a potential therapeutic for the severe dry mouth (xerostomia) experienced by...” NCT04392622 ↗4“orally administered d-limonene (limonene) and delta-9-tetrahydrocannabinol (THC)” NCT06378957 ↗ “1mg of d-limonene” NCT03609853 ↗ |
| Known as | Cajeputene | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Cinene | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Dipenten | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Dipentene | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Dipentene no. 122 | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Eulimen | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | FEMA NO. 2633 | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Kautschin | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | limonene | “A sublingual tablet containing 30 mg of cannabidiol (CBD), 1 mg tetrahydrocannabinol (THC), 97 mg palmitoylethanolamide (PEA), and a 0.2 mg combination of myrcene,...” NCT04091789 ↗3“orally administered d-limonene (limonene) and delta-9-tetrahydrocannabinol (THC)” NCT06378957 ↗ |
| Known as | Limonene, d- | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Limonene, dl- | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Nesol | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | NSC-21446 | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | NSC-757069 | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | NSC-844 | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Known as | Orange x | ChEMBL registry synonym — accepted as the source's own label CHEMBL449062 ↗ |
| Modality | Small molecule | — CHEMBL449062 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Limonene Capsule, a Chinese patent medicine, has been on the market” NCT05525260 ↗ |
| Route | Inhaled | “vaporized d-limonene and THC administered via inhalation” NCT03609853 ↗ |